Wingard JR, Leather HL. Empiric antifungal therapy for the neutropenic patient. Oncology. 2001;15(3):351–364.
Datos en archivo, MSD.
Nelsen Khan J, Hsu MJ, Racine F, y cols. Caspofungin susceptibility in aspergillus and non-aspergillus molds: inhibition of glucan synthase and reduction of ß-D-1,3 glucan levels in culture. Antimicrob Agents Chemother. 2006; 50(6):2214–2216.
